Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing

British Journal of Dermatology

Volumn 138, Issue 2, 1998, Pages 277-282

  Ure, I ^a   Partsch, B ^a   Wolff, K ^a   Petzelbauer, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8;

ADULT; ARTICLE; CELL GROWTH; DERMIS; HUMAN; INFLAMMATORY CELL; MALE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; SKIN INJURY; WOUND HEALING;

ADULT; ARTHRALGIA; DOUBLE-BLIND METHOD; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HEADACHE; HUMANS; INTERLEUKIN-8; MALE; NAUSEA; STATISTICS, NONPARAMETRIC; SWEATING; WOUND HEALING; WOUNDS, PENETRATING;

EID: 0031893634     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02074.x     Document Type: Article

References (26)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7.
2. Martin P, Hopkinson-Woolley J, McCluskey J. Growth factors and cutaneous wound repair. Prog Growth Factor Res 1992; 4: 25-44.
3. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73: 333-46.
4. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 1995; 19: 431-44.
5. Hancock GE, Kaplan G, Cohn ZA. Keratinocyte growth regulation by the products of immune cells. J Exp Med 1988; 1681: 395-402.
6. Dedhar S, Gaboury L, Galloway P, Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 1988; 85: 9253-7.
7. Bussolino F, Wang JM, Defilippi P et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337: 471-3.
8. Bussolino F, Ziche M, Wang JM et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 1991; 87: 986-95.
9. Robson M, Kucukcelebi A, Carp SS et al. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur J Clin Microbiol Infect Dis 1994; 13: S41-6.
10. Jyung RW, Wu L, Pierce GF, Mustoe TA. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surg 1994; 115: 325-34.
11. Kaplan G, Walsh G, Guido LS et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 1992; 175: 1717-28.
12. Braunstein S, Kaplan G, Gottlieb AB et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol 1994; 103: 601-4.
13. Marques dCR, Jesus FM, Aniceto C, Mendes M. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. Am J Surg 1997; 173: 165-8.
14. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464-6.
15. Swensson O, Schubert C, Christophers E, Schröder JM. Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J Invest Dermatol 1991; 96: 682-9.
16. Wysocki AB, Staiano CL, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 64-8.
17. Young PK, Grinnell F. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 1994; 103: 660-4.
18. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from pressure ulcers contain elevated matrix metallo-proteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-8.
19. Marikovsky M, Breuing K, Liu PY et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 1993; 90: 3889-93.
20. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. A study of cytokines in blister fluid related to wound healing. Burns 1995; 21: 352-5.
21. McCarthy DW, Downing MT, Brigstock DR et al. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J Invest Dermatol 1996; 106: 49-56.
22. Andree C, Swain WF, Page CP et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 1994; 91: 12188-92.
23. Vyalov S, Desmouliere A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 63: 231-9.
24. Piguet PF, Grau GE, de Kossodo S. Role of granulocyte-macrophage colony-stimulating factor in pulmonary fibrosis induced in mice by bleomycin. Exp Lung Res 1993; 19: 579-87.
25. Maurer D, Stingl G. Wound healing. In Marty M, ed. Manual of GM-CSF. Oxford: Blackwell Science, 1996; 208-18.
26. Jones TC. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF). Stem Cells 1994; 12 (Suppl. 1): 229-39.